The National Perspectives Plenary Session is new this year and was created to provide the opportunity for leaders of federal agencies to address emerging issues and advances in addiction medicine with short, pointed presentations. Attendees will have the opportunity to ask questions of agency leaders during the last half of the session. Moderated by ASAM President, R. Jeffrey Goldsmith, MD, DLFAPA, DFASAM and Annual Conference Program Planning Committee Chair, Michael Fingerhood MD, FACP, this lively session will give attendees the opportunity to interact with representatives from SAMHSA, NIAAA, and NIDA.
Ms. Enomoto has been delegated—by the Department of Health and Human Services Secretary Sylvia M Burwell—the functions, duties, and authorities of the Administrator to oversee an agency with four centers, four offices, over 600 employees, and a budget of $3.7 billion. Through data, policy, public education, and grants, Ms. Enomoto and the SAMHSA team advance the agency's mission to reduce the impact of substance abuse and mental illness on America's communities. Ms. Enomoto has served as Principal Deputy Administrator and principal advisor to the SAMHSA Administrator on operations, policies, and programmatic activities for the agency since August 2011. Prior to that, Ms. Enomoto served as the Director of the Office of Policy, Planning, and Innovation, where she developed, coordinated, and communicated SAMHSA policies across the full spectrum of mental health and substance abuse issues. From 2005-2009, Ms. Enomoto served as the Principal Senior Advisor to three SAMHSA Administrators, and as the Acting Deputy Administrator between 2008 and 2009. She began her tenure at SAMHSA in 1998 as a Presidential Management Fellow. She began her career in research and clinical services with a focus on minority mental health and trauma. Ms. Enomoto has received awards in recognition of her work, including the Arthur S. Flemming Award, the American College of Mental Health Administration King Davis Award, and the Secretary's Award for Distinguished Service. Ms. Enomoto earned her bachelor's degree in psychology and master's degree in clinical psychology from the University of California, Los Angeles and is a graduate of Harvard University's Kennedy School of Government, Senior Managers in Government Program.
George F. Koob
George F. Koob, PhD is Director of the National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health, Washington, DC. As an authority on alcoholism, drug addiction and stress, he has contributed to our understanding of the neurocircuitry associated with the acute reinforcing effects of alcohol and drugs of abuse and the neuroadaptations of the reward and stress circuits associated with the transition to dependence. Dr. Koob has published over 650 peer reviewed papers and several books including the “Neurobiology of Addiction," a comprehensive treatise on emerging research in the field. He has mentored 11 PhD students and over 75 post-doctoral fellows.
Dr. Wilson M. Compton serves as the Deputy Director of the National Institute on Drug Abuse (NIDA) of the National Institutes of Health. In his current role, Dr. Compton's responsibilities include providing scientific leadership in the development, implementation, and management of NIDA's research portfolio and working with the Director to support and conduct research to improve the prevention and treatment of drug abuse and addiction. Prior to his current appointment, Dr. Compton served as the Director of NIDA's Division of Epidemiology, Services and Prevention Research from 2002 until 2013. In this leadership role, he oversaw the scientific direction of a complex public health research program of national and international scope addressing: 1) the extent and spread of drug abuse, 2) how to prevention drug abuse, and 3) how to implement drug abuse prevention and treatment services as effectively as possible. Before joining NIDA, Dr. Compton was Associate Professor of Psychiatry and Director of the Master in Psychiatric Epidemiology Program at Washington University in Saint Louis as well as Medical Director of Addiction Services at the Barnes-Jewish Hospital in Saint Louis. Dr. Compton received his undergraduate education from Amherst College. He attended medical school and completed his residency training in psychiatry at Washington University. During his career, Dr. Compton has achieved multiple scientific accomplishments: he was selected to serve as a member of the DSM-5 Revision Task Force; is the author of more than 130 articles and chapters; and is an invited speaker at multiple high-impact venues. Dr. Compton is the recipient of multiple awards and in 2008, he received the Senior Scholar Health Services Research Award from the American Psychiatric Association, in 2010 the Paul Hoch Award from the American Psychopathological Association, in both 2012 and 2013, he was selected to receive the Leveraging Collaboration Award from the Food and Drug Administration. In 2013, Dr. Compton received the prestigious Health and Human Services Secretary's Award for Meritorious Service.